A straightforward method for meeting FDA Requirements for Design Inputs and Outputs

Overview
A robust DIOM can serve as the foundation for meeting FDA requirements and is a useful tool to ensure future iterations, changes, and re-visits to the initial design are clearly documented. A DIOM ensures design information is clearly presented, well-documented, and most importantly, located within one simple document. This webinar provides a simplistic tool to help identify and categorize design inputs, determine the most effective method in providing design output evidence, and showing traceability to all activities associated with both.

The speaker has worked on numerous design development projects in Class II and Class III medical devices as well as establishing Quality Management Systems which include easy-to-understand methods to meet design development and design control requirements. This webinar will walk you through step-by-step how to complete a DIOM for your product and simplify this often overly complex process.

Why should you Attend
Better understanding of FDA regulations with regards to design input and output
An organized approach in meeting design input and output requirements
A simplified way to ensure design inputs and outputs are continually maintained and tracked
Areas Covered in the Session
Introduction to the DIOM template
How to identify your design inputs
How to categorize your design inputs and their sources
Ways in which design inputs can be verified
Common documents and activities used as design output evidence
Additional requirements of design inputs and outputs
Who Will Benefit
Quality Assurance
Regulatory Affairs
Design Engineers
Manufacturing Engineers
Startup Companies
Speaker Profile
Denise Wrestler ASQ CQE, CQA; QA/RA Consultant at CYA Medical Device Consulting, LLC with almost 15 years of experience within FDA-regulated industries including medical device and pharmaceuticals, Ms. Wrestler provides quality, regulatory, and technical expertise to meet individual client needs. Ms. Wrestler agrees with the FDA's "least burdensome approach" and prides herself on providing options and recommendations for ensuring regulations are met without wasting precious company resources.

Need more targetted audience? 90% OFF.

PROMOTE NOW
Quick Links
Resources
The Conference Alerts

If you have any suggestion / complain to improve this community, please write us - [email protected]